Retrieved from Ushakumari DS, Sladen RN
We tend to follow these guidelines, as the medications are very expensive if not covered. As effective as they are, she says, GLP-1s are not a quick fix, and theyre not for people who need or want to lose the 10-15 pounds that can accompany the transition into midlife (for those folks, Gennevs menopause-trained MDs and RDNs have many weight management strategies that can be tailored to patient goals)
But until we do longer-term studies of which people taking it now, essentially, will be the guinea pigs then were not going to know definitively whether this is going to be safe long term, or whether it is safer as a short-term intervention. But people may not want to only use semaglutide as a short-term measure, because its effects only last as long as people are on it
Every formulation is guided by peer-reviewed evidence, tested for purity, and designed for measurable results